SYRS: Syros Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SYRS: Syros Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 138.99
Enterprise Value ($M) 40.68
Book Value ($M) 16.66
Book Value / Share 0.62
Price / Book 8.34
NCAV ($M) -6.53
NCAV / Share -0.24
Price / NCAV -21.28

Profitability (mra)
Return on Invested Capital (ROIC) -2.09
Return on Assets (ROA) -0.80
Return on Equity (ROE) -1.54

Liquidity (mrq)
Quick Ratio 3.95
Current Ratio 3.95

Balance Sheet (mrq) ($M)
Current Assets 144.98
Assets 168.17
Liabilities 151.51
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.94
Operating Income -126.50
Net Income -164.57
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -109.71
Cash from Investing 37.34
Cash from Financing 43.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Blue Owl Capital Holdings LP 5.74
02-13 13G/A Ally Bridge MedAlpha Master Fund L.P. 2.60 -60.33
02-13 13G/A Bain Capital Life Sciences Fund II, L.P. 9.99 29.42
02-13 13G/A Avidity Partners Management LP 9.90 21.58
02-09 13G/A Artal International S.C.A. 9.90 143.80
02-07 13G/A Adage Capital Partners Gp, L.l.c. 9.99 109.28
01-02 13G Point72 Asset Management, L.P. 5.70
12-26 13D/A Samsara BioCapital, L.P. 9.50 56.68

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-08 10-Q pa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 6,324 45,197 13.99
2024-05-02 24,204 301,219 8.04
2024-05-01 21,218 62,026 34.21
2024-04-30 10,230 29,644 34.51
2024-04-29 24,940 25,157 99.14

(click for more detail)

Similar Companies
SVRA – Savara Inc. SWTX – SpringWorks Therapeutics, Inc.
SYRE – Spyre Therapeutics, Inc. TARS – Tarsus Pharmaceuticals, Inc.
TBIO – Telesis Bio, Inc.


Financial data and stock pages provided by
Fintel.io